The pattern of induction of apoptosis during infection with MHV-3 correlates with strain variation in resistance and susceptibility to lethal hepatitis

Advances in Experimental Medicine and Biology

Volumn 440, Issue , 1998, Pages 619-625

  Belyavskyi, Michail ^a   Levy, Gary A ^b   Leibowitz, Julian L ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; GENETIC VARIABILITY; MACROPHAGE; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRAIN DIFFERENCE; SYNCYTIUM; VIRUS HEPATITIS; VIRUS RESISTANCE;

ANIMALS; APOPTOSIS; BROMODEOXYURIDINE; CELLS, CULTURED; DISEASE SUSCEPTIBILITY; GENE EXPRESSION; IMMUNITY, NATURAL; MACROPHAGES, PERITONEAL; MICE; MURINE HEPATITIS VIRUS; THROMBOPLASTIN;

ANIMALIA; CORONAVIRUS; MURINAE; MURINE HEPATITIS VIRUS;

EID: 0031754154     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5331-1_80     Document Type: Article

References (11)

1. Belyavskyi, M., Miller, J., and Wilson, V., 1994, The bovine papillomavirus El protein alters the host cell cycle and growth properties, Virology 204:132-143.
2. Cuff, S., and Ruby, J., 1996, Evasion of apoptosis by DNA viruses, Immun.Cell Biol. 74: 527-537.
3. Dindzans, V., MacPhee, P., Fung, L., Leibowitz, J., and Levy, G., 1985, The immune response to mouse hepatitis virus: expression of monocyte procoagulant activity and plasminogen activator during infection in vivo, J. Immunol. 135:4189-4197.
4. Dindzans, V., Skamene, E., and Levy, G., 1986, Susceptibility/resistance to mouse hepatitis virus strain 3 and macrophage procoagulant activity are genetically linked and controlled by two non-H2-linked genes, J. Immunol. 137:2355-2360.
5. Levy, G. A., J. L. Leibowitz, and T. S. Edgington., 1981, The induction of monocyte procoagulant activity by murine hepatitis virus MHV-3 parallels disease susceptibility in mice, J. Exp. Med. 154:1150-1163.
6. Levy, G., MacPhee, P., Fung, L., Fisher, M., and Rappaport, A., 1983, The effect of mouse hepatitis virus infection on microcirculation of the liver, Hepatology 3: 964-973.
7. Macnaughton, M., and Patterson, S., 1980, Mouse hepatitis virus strain 3 infection of C57, A/Sn and A/J strain mice and their macrophages, Arch. Virol. 66:71-75.
8. Parr, R. L., Fung, L. S., Reneker, S. J., Myers-Mason, N., Leibowitz, J. L., and Levy, G. A., 1995, Association of mouse fibrinogen like protein (musfiblp) with murine hepatitis virus induced prothrombinase activity, J. Virol. 69:5033-5038.
9. Piazza, M., 1969, "Experimental viral hepatitis". CA Thomas, Springfield, IL.
10. Schutte, B., Reynders, M., van Assche, C. L. M., Hupperets, P. S. G. J., Bosman, F. T., and Blijham, G. H., 1987, An improved method for the immunocytochemical detection of bromodeoxyuridine labeled nuclei using flow cytometry, Cytometry 8:372-376.
11. Wyllie, A. H., Kerr, J. F. R., and Currie, A. R., 1980, Cell death: The significance of apoptosis, Int. Rev. Cytology 68:251-306.